Focus Diagnostics Recalls Stratify JCV DxSelect Assay Due to False Positive Risk
Focus Diagnostics is recalling 300 units of the Stratify JCV DxSelect assay (Lot 27333) because a non-conforming batch may cause false positive results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard is a potential for false positive results, which is a diagnostic accuracy issue rather than a direct physical injury or high-risk pathogen exposure, fitting the criteria for moderate severity.
Plain-English summary
Focus Diagnostics Inc is recalling 300 units of the STRATIFY JCV DxSelect, Model No. EL1950, an in vitro diagnostic assay used to detect antibodies to JC Virus in human serum or plasma. The recall affects Lot No. 27333, which was distributed internationally to Denmark only.
The recall was initiated because a non-conforming batch was used in the manufacture of the affected kits. This manufacturing issue could lead to a potential for false positive JCV results.
No specific instructions for consumers or healthcare providers are provided in the source text regarding immediate actions to take, such as stopping use or contacting a representative.
The recalled product
- Product
- STRATIFY JCV DxSelect, Model No. EL1950. Assay for detection of antibodies to JC Virus in human serum or plasma. In Vitro diagnostic.
- Manufacturer
- Focus Diagnostics Inc
- Hazard
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot No. 27333
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Focus Diagnostics Inc
See all →- LowFocus Diagnostics Legionella IFA Recalled for Regulatory Status Error
FDA (Devices) · 2017-04-05
- ModerateFocus Diagnostics Legionella IFA Substrate Slide Recalled for Regulatory Status
FDA (Devices) · 2017-04-05
- ModerateFocus Diagnostics Recalls Simplexa HSV 1&2 Direct Amplification Discs
FDA (Devices) · 2016-04-13
- HighFocus Diagnostics Recalls Simplexa Group A Strep Direct Amplification Discs
FDA (Devices) · 2016-04-13
- HighFocus Diagnostics Recalls Simplexa Direct Amplification Discs for Diagnostic Errors
FDA (Devices) · 2016-04-13
Same hazard · false positive result
See all →- HighSequencing Agent SEQ0067 Component Recalled for Potential False-Positive Results
FDA (Devices) · 2026-04-29
- HighStratus CS Acute Care cTNI TestPak cardiac troponin test recall
FDA (Devices) · 2025-05-07
- HighBlood Culture Identification Panel May Produce False Positive Results
FDA (Devices) · 2024-08-07
- HighbiokitHSV-2 Rapid Test Recalled for Potential False Positive Results
FDA (Devices) · 2023-02-01
- ModerateSiemens Allergen Test Kit Recall: False Positive Mold Results
FDA (Devices) · 2022-12-21